Rockefeller Capital Management »

Rani Therapeutics Hldgs shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.8k 12k 0.76

More positions owned by Rockefeller Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tidal Trust Iii Rock Gl Equi Etf (RGEF)
Tidal Trust Iii Rock Us Smal Etf (RSMC)

View all positions for Rockefeller Capital Management

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
RA Capital Management
AWM Investment Company
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Polar Securities
Siren
Heights Capital Management
Geode Capital Management
Citadel Advisors
Marshall Wace
Jane Street
Nan Fung Group Holdings
Vanguard Fiduciary Trust

View all funds holding Rani Therapeutics Hldgs